Concomitant Cephalosporins or Vancomycin During or After Treatment of Clostridioides difficile Infection Increases Risk of 3-Month CDI Recurrence

被引：0
|
作者：
Damianos, John [1 ]
Chaar, Abdelkader [2 ]
Rizwan, Rabia [2 ]
Mansoor, Muhammad Sohail [3 ]
Sharma, Prabin [4 ]
Malik, Umer Ejaz [5 ]
Alnahhas, Houssam [6 ]
Feuerstadt, Paul [1 ,7 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
[3] GI Specialists Georgia, Marietta, GA USA
[4] NYU Langone Long Isl, Mineola, NY USA
[5] Albany Med Ctr, Albany, NY USA
[6] Syria Publ Hlth Network, London, England
[7] PACT Gastroenterol Ctr, Hamden, CT USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S207
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 35 条
  • [31] Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
    Orenstein, Robert
    Dubberke, Erik R.
    Khanna, Sahil
    Lee, Christine H.
    Yoho, David
    Johnson, Stuart
    Hecht, Gail
    DuPont, Herbert L.
    Gerding, Dale N.
    Blount, Ken F.
    Mische, Sarah
    Harvey, Adam
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [32] Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
    Robert Orenstein
    Erik R. Dubberke
    Sahil Khanna
    Christine H. Lee
    David Yoho
    Stuart Johnson
    Gail Hecht
    Herbert L. DuPont
    Dale N. Gerding
    Ken F. Blount
    Sarah Mische
    Adam Harvey
    BMC Infectious Diseases, 22
  • [33] Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset, Clostridioides difficile infection (HO-CDI) to overestimate rates
    Puri, Shruti
    Hughes, Heather Y.
    McCrackin, Monica D.
    Williford, Robert
    Gebregziabher, Mulugeta
    Salgado, Cassandra D.
    Curry, Scott R.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (04): : 467 - 468
  • [34] Local Recurrence Rates following Equivocal 3-month Post-Treatment PET after High Dose Rate Brachytherapy for Locally Advanced Cervical Cancer: An Updated Cohort
    Harris, E.
    Shenker, R. F.
    Lee, J. W. C.
    Stephens, S. J.
    Ayala-Peacock, D. N.
    Chino, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E689 - E689
  • [35] TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAAS) NEITHER INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA PROGRESSION DURING WAITING LIST NOR RECURRENCE AFTER LIVER TRANSPLANTATION
    Pinero, Federico
    Boin, Ilka
    Rubinstein, Fernando
    Chagas, Aline
    Quinonez, Emilio
    Marciano, Sebastian
    Vilatoba, Mario
    Varon, Adriana
    Anders, Margarita
    Hoyos Duque, Sergio
    Lima, Agnaldo Soares
    Menendez, Josemaria
    Padilla, Martin
    Poniachick, Jaime
    Zapata, Rodrigo
    Barrabino, Martin
    Chong Menendez, Ricardo
    Munoz, Linda
    Arufe, Diego
    Figueroa, Rodrigo
    Mendizabal, Manuel
    Zanaga, Leticia
    Maccali, Claudia
    Vergara Sandoval, Rodrigo
    Barmudez, Carla
    Beltran, Oscar
    Aenas, Isabel
    Gerona, Solange
    Iracheta, Alexis
    Ginesta, Alexandra
    Gadano, Adrian
    Mattera, Juan
    Stucchi, Raquel
    Carrillo, Flair
    Silva, Mauricio
    TRANSPLANT INTERNATIONAL, 2019, 32 : 407 - 407
1234